Komori
Techno Medica (6678) · RiskRestated

Risk of Patent Infringement and Intellectual Property Rights Protection

First written in FY2017. 4 of 5 entries say "Restated". Latest entry: FY2024.

5entries
8years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017 – FY20242017: 120172018: 120182019: 120192020: 020202021: 020212022: 120222023: 020232024: 12024
Same theme, other companies
Risk of Infringing Third-Party Intellectual Property RightsA theme 465 companies write about · 468 as a headwind · 1 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 197 companies compared. The sentences above are computed from all 197.Comparing 200 of the theme's 469 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2024RestatedAnnual report

    「Because competitors may hold patents similar to our registered patents, it is essential in product development to monitor these developments carefully, both to prepare for litigation and to protect the intellectual property rights relating to new research and development.」

    The company continues to protect its intellectual property rights and monitor competing patent developments in light of the potential for litigation involving similar competitor patents.
  2. FY2022RestatedAnnual report

    「Because competitors may hold patents similar to our registered patents, it is essential in product development to monitor these developments carefully, both to prepare for litigation and to protect the intellectual property rights relating to new research and development.」

    The company continues to protect its intellectual property rights and monitor competing patent developments in light of the potential for litigation involving similar competitor patents.
  3. FY2019RestatedAnnual report

    「Because competitors may hold patents similar to our registered patents, it is essential in product development to monitor these developments carefully, both to prepare for litigation and to protect the intellectual property rights relating to new research and development.」

    The company continues to protect its intellectual property rights and monitor competing patent developments in light of the potential for litigation involving similar competitor patents.
  4. FY2018RestatedAnnual report

    「Because competitors may hold patents similar to our registered patents, it is essential in product development to monitor these developments carefully, both to prepare for litigation and to protect the intellectual property rights relating to new research and development.」

    The company continues to protect its intellectual property rights and monitor competing patent developments in light of the potential for litigation involving similar competitor patents.
  5. FY2017First statedAnnual report

    「Because competitors may hold patents similar to our registered patents, it is essential in product development to monitor these developments carefully, both to prepare for litigation and to protect the intellectual property rights relating to new research and development.」

    In light of the potential for litigation involving competitors’ patents similar to the company’s registered patents, the company identifies protection of intellectual property rights and monitoring of competing patents as key challenges.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Techno Medica yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Risk of Patent Infringement and Intellectual Property Rights Protection | Techno Medica Co.,Ltd. (6678) | Komori